4D MOLECULAR THERAPEUTICS IN

Ticker: FDMT CUSIP: 35104E100 Class: Common Stock

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 16,400 Value ($000) $143 Avg Close $5.98 Range $3.68 - $8.72

Q1 2025

Shares 14,800 Value ($000) $48 Avg Close $4.71 Range $3.17 - $6.91

Q2 2024

Shares 11,079 Value ($000) $233 Avg Close $25.09 Range $20.33 - $31.87

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	16,400	$143	$5.98	$3.68 - $8.72
Q1 2025	14,800	$48	$4.71	$3.17 - $6.91
Q2 2024	11,079	$233	$25.09	$20.33 - $31.87